Yes I suppose at 15c (1.2B) I think it was wildly overvalued then - for a company with PH1's. Again I think of biotech companies on the ASX in the Billions - like Meso, Clarity, Telix, neuren, they all have PHase 2's and many Phase 3s'.
I think, when the vaxinia data + oasis comes out later in year, it may spike to 4-5c, but not much higher. Then down again, until pHase 2's start completion - I think 15-20c is probably 18mths (even 24 months away)
IMU Price at posting:
4.1¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)